Diffuse malignant pleural mesothelioma: Part I. An overview of diagnosis, staging, and treatment options.
Diffuse malignant mesothelioma is an uncommon, aggressive malignancy that occurs most often in the pleura of the lung. This article reviews the risk factors, incidence, signs, symptoms, diagnosis, staging, treatment options, and follow-up care of diffuse malignant pleural mesothelioma (DMPM). Curative approaches for treating DMPM are limited, and survival rates rarely exceed two years. Treatments such as surgery, chemotherapy, and radiotherapy have shown limited benefit in improving survival. Extrapleural pneumonectomy combined with multimodal treatments provides a potentially curative approach, and newer efforts in multimodality therapy are promising. Clinical trials utilizing intrapleural chemo-photodynamic, gene, and immunotherapies currently are under way.
Brueggen
Carol
C
Brueggen.carol@mayo.edu
Cordes
Mary Ellen
ME
D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D006801:Humans; D008654:Mesothelioma / Q000000981:diagnostic imaging* / Q000628:therapy*; D009367:Neoplasm Staging; D010166:Palliative Care / Q000379:methods; D010997:Pleural Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy*; D014057:Tomography, X-Ray Computed